Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Premier Healthcare Pitch Competition comes to Atlanta this May

Abstract:
Round2Funding invites early stage healthcare Companies to apply for THE MAIN EVENT to be held May 17th at the Georgia Tech Conference Center. Companies will have the opportunity to present to medical experts, industry professionals, successful healthcare entrepreneurs and Investors. All finalists will be invited to join Round2Funding, an invitation-only investment portal directly connecting accredited Investors and vetted healthcare Companies. Round2Funding focuses on healthcare startups seeking $1 to $5 million in investments and allows Investors to anonymously evaluate these vetted healthcare Companies.

Premier Healthcare Pitch Competition comes to Atlanta this May

Atlanta, GA | Posted on April 12th, 2014

"Raising capital can be a daunting and strenuous process, but it does not have to be," says Chris Fair, founder and President of Round2Funding, Inc. "By providing companies with the correct tools to successfully raise capital and connect them with the right Investors, the fundraising process can be seamless."

According to the Wall Street Journal, "[medical startup and biotechnology] first round financing is on pace to reach $259.73 million this year, less than half the amount in 2007 and down 21% from last year." Companies are now turning to family offices and high net worth individuals for funding. Companies however, have a hard time finding Family Offices and individual Investors. Mr. Fair knew there was an opportunity to capitalize on the healthcare Companies not just in Southeast, but across the globe.

Round2Funding's Investor network is targeted towards Family Offices, high net worth individuals, and large angel groups. Round2Funding Investors are looking to invest in healthcare startups transitioning from product validation to commercialization. Round2Funding seeks to simplify the match making process by providing Investors with a secure portal to view healthcare startups while maintaining their anonymity.

"With little effort on our end, Round2Funding enables us to review deal flow we may not find on our own while keeping our identity private," says Will Loving, Altron Investments.

Round2Funding is now accepting applications for The MAIN EVENT at www.round2funding.com/main-event.

####

About Round2Funding, Inc.
Round2Funding is an invitation-only investment portal that directly connects vetted healthcare Companies with accredited Investors. Round2Funding was created to address the needs of early stage healthcare Companies attempting to raise capital and investment institutions looking to invest directly in quality, vetted healthcare opportunities. Round2Funding aims to provide a credible alternative to the current broker dealer model.

For more information, please click here

Contacts:
Chakshu Mehta
770-235-4895


Chakshu Mehta
Project Manager
MEDTOWN Ventures
(770) 235-4895 Cell
(855) MEDTOWN (633-8696)
www.medtownventures.com

Copyright © Round2Funding, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Doubling down on Schrödinger's cat May 27th, 2016

Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Oxford Nanoimaging to provide desktop super-resolution microscopes May 10th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Nanomedicine

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Supercrystals with new architecture can enhance drug synthesis May 24th, 2016

Nanoscale Trojan horses treat inflammation May 24th, 2016

Announcements

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Doubling down on Schrödinger's cat May 27th, 2016

Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016

Events/Classes

Novel gene therapy shows potential for lung repair in asthma May 18th, 2016

Arrowhead Pharmaceuticals' Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration May 10th, 2016

Nanometrics Announces Upcoming Investor Events May 10th, 2016

Oxford Instruments Asylum Research and McGill University Announce the McGill AFM Summer School and Workshop, May 12-13, 2016 May 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic